ZEON Corp. engages in the production and sale of synthetic rubbers and specialty plastics. It operates through the following segments: Elastomer Materials Business, Specialty Materials Business, and Others. The Elastomer Materials Business segment includes synthetic rubbers used in automobile tires and conveyer belts; synthetic lattices used in tires and adhesives; and chemical products such as resins and inks. The Specialty Materials Business segment comprises of synthetic aroma chemicals and other industrial chemicals; information and imaging materials; specialty plastics for optical lenses; and medical products. The Others segment consists of paints, butadiene extraction technology, and reaction injection molding (RIM) formulations and products. The company was founded on April 12, 1950 and is headquartered in Tokyo, Japan.

Established in 1992 as an export-oriented unit (EOU), Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing. We today rank among the top 15 pharmaceutical companies in India and enjoy a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardio vascular segment (CVS), nutraceuticals and other oral and sterile products. Their pharmaceutical solutions include active pharmaceutical ingredients (API), finished dosage forms, new drug discovery (NDD), novel drug delivery systems (NDDS) and contract research and manufacturing services (CRAMS). They are globally present across 70+ countries through alliances, joint ventures and partnerships with globally reputed majors.

Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France.

Ningbo Ziyuan Pharmaceutical Co., Ltd., established on 2015-07-29, Business scope includes research and development of biomedicine,Biomedical production project preparation.

Nippon Zeon Co., Ltd., part of BASF SE, is a company headquartered in Tokyo, Japan. The firm manufactures speciality liquid resins. It was acquired by Ciba Holding AG on March 01, 1998.

Syngenta AG is a global company that produces agrochemicals and seeds and is based in Basel, Switzerland. As a biotechnology company, it conducts genomic research. It was formed in 2000 by the merger of Novartis Agribusiness and Zeneca Agrochemicals. As of 2014 Syngenta is the world’s largest crop chemical producer As of 2009 it ranked third in seeds and biotechnology sales. Sales in 2015 were approximately US$13.4 billion, over half of which were in emerging markets. It is owned by ChemChina, a Chinese state-owned enterprise.

Zeneca is a British multinational pharmaceutical company focused on therapeutic oncology and cardiovascular products. Zeneca was established in June 1993 through a demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries. In 1999 Zeneca and Astra AB, a Sweden-based pharmaceutical company, merged to form AstraZeneca plc.

The Czechoslovak Academy of Sciences (Czech: Československá akademie věd, Slovak: Česko-slovenská akadémia vied) was established in 1953 to be the scientific center for Czechoslovakia. It was succeeded by the Czech Academy of Sciences (Akademie věd České republiky) and Slovak Academy of Sciences (Slovenská akadémia vied) in 1992.

Estabished in1950, Snow Brand Milk Products Co. Ltd. is a Japanese dairy company that manufactures cheese, butter, milk and other dairy products. They also manufacture fruit juices and frozen desserts and offers home milk delivery service. Snow Brand has several offices and factories around Japan.

Yamasa Corp. manufactures and supplies soy sauce and seasonings. It processes and supplies soy sauce, seasonings, sauces, dips, and flavorings. The firm also develops pharmaceuticals and biochemicals. The company was founded in 1645 and is headquartered in Choshi, Japan.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Taizhou Huifeng Hetai Biotechnology Co., Ltd., established on 2021-05-08, Business scope includes licensed projects:Import and export;Technology Import and Export;Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Intellectual Property Services;Sales of Class I Medical Devices;Instrument sales;Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Huaanfo Pharmaceutical Research Center Co., Ltd., established on 2003-01-29, Business scope includes pharmacogenomics,predictive medicine,Cancer Genomics,Technology development of new drugs,technology transfer,technical consulting.(Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments.)

Shenzhen Ausa Pharmed Co. Ltd. is a private company headquartered in China. The firm provides drug clinical trail services.

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Material Solutions, Quality of Life Solutions, Health Care Solutions, Nutrition Solutions and Others. The Material Solutions segment covers biodegradable polymers, materials that support the development of social infrastructure and mobility which includes the weight reduction and fuel efficiency improvement. The Quality of Life Solutions segment handles energy saving needs such as housing and living infrastructure, and development of Internet of things (IoT) and artificial intelligence (AI). The Health Care Solutions segment offers solutions through the fusion of devices and medicines, and develops healthcare business based on biopharmaceuticals and regenerative and cellular medicines. The Nutrition Solutions segment provides materials and supplement solutions to food production support in livestock and fishery industries. The Others segment provides agency services for property and life insurance. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.